Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuronal acetylcholine receptor (nAChR) subunit alpha refers to a family of protein subunits that form part of the nicotinic acetylcholine receptors in the nervous system. These receptors are ligand-gated ion channels activated by the neurotransmitter acetylcholine and are crucial for fast synaptic transmission in both central and peripheral nervous systems. There are ten known neuronal alpha subunits in mammals, named α2 through α10 (α1 is primarily found in muscle-type nAChRs). Each nAChR is a pentamer composed of five subunits, which can be either homomeric (all identical, e.g., α7) or heteromeric (combinations of different alpha and beta subunits). Upon binding acetylcholine, these receptors undergo conformational changes that open an ion channel permeable to cations such as Na(+), K(+), and Ca(2+). This leads to depolarization of neurons or muscle cells, facilitating neurotransmission. Different combinations of alpha subunits confer distinct pharmacological properties and physiological roles. Alterations or mutations in genes encoding neuronal nAChR alpha subunits have been linked with neurodegenerative diseases, cognitive deficits, and attention-deficit/hyperactivity disorder (ADHD). Pharmacological targeting of specific nAChR alpha-containing complexes is being explored for therapeutic interventions against these conditions.
Agonist or antagonist binding to the receptor, leading to ion channel opening or blockade, respectively.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuronal Acetylcholine Receptor Subunit Alpha (nAChR alpha subunit).